Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-18

Clinical Trial Update: P2 Study of Postoperative Interferon/Fluorouracil vs Cisplatin/Fluorouracil for Hepatocellular Carcinoma. [Phase 2]

View source ↗

Summary

Phase 2 postoperative trial comparing interferon plus fluorouracil versus cisplatin plus fluorouracil for hepatocellular carcinoma; current trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • CISPLATIN (cisplatin)
  • Interferon Alfa (interferon alfa)

Snippet

Sponsor: Kansai Hepatobiliary Oncology Group | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN